Methylation as a Tool for Monitoring Colon Cancer Diversity: Technical Challenges and Possibilities
It is well known that cancer populations evolve rapidly and can undergo a wide diversification. Being able to track the evolution of a cancer cell population through informative markers has enormous potential in cancer medicine.
It is well known that cancer populations evolve rapidly and can undergo a wide diversification. Being able to track the evolution of a cancer cell population through informative markers has enormous potential in cancer medicine.
Methylation is deeply involved in several cancers, and methylation patterns are more and more used in combination with mutational and clinical information as a tool in personalized medicine.
Using the example of a study in colon cancer this talk will illustrate the state of the art in measuring methylation levels and how that information can be used to provide accurate predictions of a wide variety of cancer subtypes.
